AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35496380 — intervention group
Group type: EXPERIMENTAL
Intervention: All tablets in a starter pack once a day for 13 days
Number of subjects: 128
Study 35496380 — intervention group
Group type: EXPERIMENTAL
Intervention: Two starter packs as 8 tablets each of apremilast 10 mg and 20 mg once a day and 10 tablets of 30 mg once a day for 26 days
Number of subjects: 128
Study 33483444 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) for 12 weeks
Number of subjects: 120
Study 33483444 — intervention group
Group type: COMPARATOR
Intervention: Control group without treatment
Number of subjects: 120
Study 33483444 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 120
Study 35526164 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (1 mg/kg)
Number of subjects: 12
Study 35526164 — intervention group
Group type: COMPARATOR
Intervention: Placebo-control (0.9% saline)
Number of subjects: 12
Study 33092327 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates exercises (16 sessions, 60 minutes each, twice a week for 8 weeks)
Number of subjects: 78
Study 33092327 — intervention group
Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 78
Study 32335356 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel plus curcumin (CUC-1®, 300 mg solution, once per week)
Number of subjects: 150
Study 32335356 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel plus placebo
Number of subjects: 150
Study 35285922 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment group (systolic BP target < 120 mm Hg)
Number of subjects: 9342
Study 35285922 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment group (systolic BP target < 140 mm Hg)
Number of subjects: 9342
Study 35285922 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment group
Number of subjects: 9342
Study 35285922 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment group
Number of subjects: 9342
Study 32602450 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery group based on the Pathways to Recovery program, 1-hour session once a week for 18 weeks
Number of subjects: 24
Study 32602450 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery group based on the Pathways to Recovery program
Number of subjects: 24
Study 36122531 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive perampanel (≤12 mg/day)
Number of subjects: 309
Study 34663363 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaine (BG, 2 g/day; n=14)
Number of subjects: 29
Study 34663363 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PG, n=15)
Number of subjects: 29
Study 33191526 — intervention group
Group type: EXPERIMENTAL
Intervention: Highlighting patterns during reading
Number of subjects: 400
Study 36036746 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg once daily
Number of subjects: 476
Study 36036746 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 476
Study 32810039 — intervention group
Group type: EXPERIMENTAL
Intervention: Sofosbuvir/Ledipasvir (SOF/LDV) 400/90 mg once daily ± ribavirin
Number of subjects: 78
Study 35987770 — intervention group
Group type: EXPERIMENTAL
Intervention: Chopstick technique
Number of subjects: 0
Study 35987770 — intervention group
Group type: COMPARATOR
Intervention: Cross technique
Number of subjects: 0
Study 33136089 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic tape
Number of subjects: 40
Study 33136089 — intervention group
Group type: COMPARATOR
Intervention: Placebo tape
Number of subjects: 40
Study 32963638 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive spirometer exercise combined with inspiratory muscle training (study group, n=20)
Number of subjects: 40
Study 32963638 — intervention group
Group type: COMPARATOR
Intervention: Incentive spirometer exercise (control group, n=20)
Number of subjects: 40
Study 33387000 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-task cough testing (simultaneous tone counting)
Number of subjects: 14
Study 33387000 — intervention group
Group type: COMPARATOR
Intervention: Single-task cough testing (cough testing only)
Number of subjects: 14
Study 32911733 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot exercises daily for six weeks (Group 1)
Number of subjects: 80
Study 32911733 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Group 2)
Number of subjects: 80
Study 36153251 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid Model (HM)
Number of subjects: 0
Study 36153251 — intervention group
Group type: COMPARATOR
Intervention: In-Person (IP)
Number of subjects: 0
Study 36153251 — intervention group
Group type: COMPARATOR
Intervention: Remote Learning (RL)
Number of subjects: 0
Study 34577838 — intervention group
Group type: EXPERIMENTAL
Intervention: Auto-CPAP with SensAwake (SA) on
Number of subjects: 25
Study 34577838 — intervention group
Group type: COMPARATOR
Intervention: Auto-CPAP without SensAwake (SA) off
Number of subjects: 25
Study 32781940 — intervention group
Group type: EXPERIMENTAL
Intervention: l-NMMA (6 mg/kg, iv over 5 minutes)
Number of subjects: 10
Study 32781940 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 36093154 — intervention group
Group type: EXPERIMENTAL
Intervention: HL‐RT + AT (70–80% of 1‐RM)
Number of subjects: 79
Study 36093154 — intervention group
Group type: EXPERIMENTAL
Intervention: LL‐RT + AT (35–40% of 1‐RM)
Number of subjects: 79
Study 36093154 — intervention group
Group type: COMPARATOR
Intervention: AT (control group)
Number of subjects: 79
Study 33211152 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dosage of oral spermidine supplementation
Number of subjects: 85
Study 33211152 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower dosage of oral spermidine supplementation
Number of subjects: 85
Study 35753857 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 65
Study 35753857 — intervention group
Group type: COMPARATOR
Intervention: No VR
Number of subjects: 65
Study 34197181 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel (60 mg/m2 once every 3 weeks for three cycles before RT and 20 mg/m2 once weekly during RT)
Number of subjects: 350
Study 32782729 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone (5 mg/ml)
Number of subjects: 60
Study 32782729 — intervention group
Group type: COMPARATOR
Intervention: Tincture of Opium (TOP) (10 mg/ml)
Number of subjects: 60
Study 33954888 — intervention group
Group type: EXPERIMENTAL
Intervention: Home hospital care (including nurse and physician home visits, intravenous medications, remote monitoring, video communication, and point‐of‐care testing)
Number of subjects: 248
Study 34254256 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous iron (400 mg/week)
Number of subjects: 60
Study 34254256 — intervention group
Group type: COMPARATOR
Intervention: Low-dose intravenous iron (100 mg/week)
Number of subjects: 60
Study 32051009 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with kinesiotape (AcuKT)
Number of subjects: 60
Study 32051009 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture alone
Number of subjects: 60
Study 32051009 — intervention group
Group type: COMPARATOR
Intervention: Comparison between AcuKT and acupuncture
Number of subjects: 60
Study 32939546 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV (adenovirus serotype 26)
Number of subjects: 164
Study 32939546 — intervention group
Group type: EXPERIMENTAL
Intervention: MVA-BN-Filo (modified vaccinia Ankara)
Number of subjects: 164
Study 32939546 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster vaccination (Ad26 or MVA) on day 360
Number of subjects: 164
Study 32939546 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 164
Study 33993702 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan (32 mg)
Number of subjects: 120
Study 33993702 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg)
Number of subjects: 120
Study 33993702 — intervention group
Group type: COMPARATOR
Intervention: No Candesartan
Number of subjects: 120
Study 33993702 — intervention group
Group type: COMPARATOR
Intervention: No Metoprolol
Number of subjects: 120
Study 32633801 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic group (Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp lactis BB‐12, total cell count per capsule, 1.3 × 10^10 to 1.6 × 10^10)
Number of subjects: 310
Study 32633801 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (matched placebo)
Number of subjects: 310
Study 35681717 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate community-based exercise
Number of subjects: 80
Study 35681717 — intervention group
Group type: COMPARATOR
Intervention: Delayed community-based exercise
Number of subjects: 80
Study 34014113 — intervention group
Group type: EXPERIMENTAL
Intervention: Didactic Intervention
Number of subjects: 150
Study 34014113 — intervention group
Group type: EXPERIMENTAL
Intervention: ACCENT intervention
Number of subjects: 150
Study 34014113 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study 32535161 — intervention group
Group type: EXPERIMENTAL
Intervention: Volumetric Modulated Arc Therapy (VMAT)
Number of subjects: 165
Study 32535161 — intervention group
Group type: COMPARATOR
Intervention: Intensity Modulated Radiation Therapy (IMRT)
Number of subjects: 165
Study 32535161 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusion of Seminal Vesicles (SV) in PTV
Number of subjects: 165
Study 32535161 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Protocol Deviations
Number of subjects: 165
Study 35087138 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-Hz rTMS
Number of subjects: 20
Study 35087138 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal 2 mA tDCS
Number of subjects: 20
Study 35087138 — intervention group
Group type: COMPARATOR
Intervention: Sham (control)
Number of subjects: 20
Study 33894592 — intervention group
Group type: EXPERIMENTAL
Intervention: Postgraduate course in clinical assessment
Number of subjects: 85
Study 33894592 — intervention group
Group type: COMPARATOR
Intervention: No postgraduate course (Control)
Number of subjects: 85
Study 35288818 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (booklet)
Number of subjects: 241
Study 35288818 — intervention group
Group type: EXPERIMENTAL
Intervention: Group AB (booklet and video)
Number of subjects: 241
Study 35288818 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 241
Study 35288818 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (video)
Number of subjects: 241
Study 33218747 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 75
Study 33218747 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 75
Study 32763873 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Phone Automated System (MPAS)
Number of subjects: 555
Study 32763873 — intervention group
Group type: COMPARATOR
Intervention: Paper and Email Data Collection (PEDC)
Number of subjects: 555
Study 36036175 — intervention group
Group type: EXPERIMENTAL
Intervention: Stroke ICF‐CS based occupational therapy (two months, three sessions per week, 45 minutes each session)
Number of subjects: 25
Study 36036175 — intervention group
Group type: COMPARATOR
Intervention: Traditional occupational therapy (control group)
Number of subjects: 25
Study 32951157 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with autism spectrum disorder (ASD)
Number of subjects: 121
Study 32951157 — intervention group
Group type: COMPARATOR
Intervention: Typically developing (TD) controls
Number of subjects: 121
Study 35274356 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid closed‐loop insulin delivery
Number of subjects: 30
Study 35274356 — intervention group
Group type: COMPARATOR
Intervention: Sensor‐augmented pump therapy
Number of subjects: 30
Study 35274356 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote monitoring technology
Number of subjects: 30
Study 33822015 — intervention group
Group type: EXPERIMENTAL
Intervention: CYD-TDV (tetravalent dengue vaccine)
Number of subjects: 0
Study 33822015 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32106780 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-infrared spectroscopy-derived total haemoglobin ([tHb])
Number of subjects: 12
Study 32106780 — intervention group
Group type: EXPERIMENTAL
Intervention: SmO2 reperfusion slope (SmO2_slope)
Number of subjects: 12
Study 35201949 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline Human Body Model (HBM)
Number of subjects: 3
Study 35201949 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized Human Body Model (HBM)
Number of subjects: 3
Study 35201949 — intervention group
Group type: COMPARATOR
Intervention: Post mortem human subjects (PMHS) tests
Number of subjects: 3
Study 33413075 — intervention group
Group type: EXPERIMENTAL
Intervention: Fremanezumab quarterly (675 mg)
Number of subjects: 857
Study 33413075 — intervention group
Group type: EXPERIMENTAL
Intervention: Fremanezumab monthly (225 mg)
Number of subjects: 857
Study 33413075 — intervention group
Group type: EXPERIMENTAL
Intervention: Fremanezumab
Number of subjects: 857
Study 33345890 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraamniotic infection
Number of subjects: 2241
Study 33345890 — intervention group
Group type: COMPARATOR
Intervention: Clinical chorioamnionitis
Number of subjects: 2241
Study 35902075 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic aerobic training (AERO)
Number of subjects: 57
Study 35902075 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic combined training (COMBI)
Number of subjects: 57
Study 35902075 — intervention group
Group type: COMPARATOR
Intervention: Aquatic active procedure control
Number of subjects: 57
Study 35902075 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 57
Study 32621555 — intervention group
Group type: EXPERIMENTAL
Intervention: Climate intervention (12 x 40-minute lessons)
Number of subjects: 2190
Study 32621555 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventure intervention (2 x 90-minute sessions)
Number of subjects: 2190
Study 32621555 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined prevention (CAP)
Number of subjects: 2190
Study 32621555 — intervention group
Group type: COMPARATOR
Intervention: Health education as usual (control)
Number of subjects: 2190
Study 33155562 — intervention group
Group type: EXPERIMENTAL
Intervention: Boss-Holzach-Matter (BHM) technique
Number of subjects: 60
Study 33155562 — intervention group
Group type: COMPARATOR
Intervention: Spaso (Sp) method
Number of subjects: 60
Study 34061693 — intervention group
Group type: COMPARATOR
Intervention: E-mails emphasizing public health values (PH values) without the word abortion
Number of subjects: 302
Study 34061693 — intervention group
Group type: EXPERIMENTAL
Intervention: E-mails using the word abortion
Number of subjects: 302
Study 34061693 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (PH values and abortion messaging)
Number of subjects: 302
Study 34326283 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir
Number of subjects: 222
Study 34326283 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted atazanavir
Number of subjects: 222
Study 34326283 — intervention group
Group type: EXPERIMENTAL
Intervention: Darunavir
Number of subjects: 222
Study 32520991 — intervention group
Group type: EXPERIMENTAL
Intervention: l-serine (594 mg daily) and EPA (149 mg daily)
Number of subjects: 120
Study 32520991 — intervention group
Group type: EXPERIMENTAL
Intervention: l-serine and EPA
Number of subjects: 120
Study 35984848 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced load (80% body weight)
Number of subjects: 0
Study 35984848 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal load (100% body weight)
Number of subjects: 0
Study 35984848 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased load (120% body weight)
Number of subjects: 0
Study 35984848 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 33341518 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-applied tape
Number of subjects: 53
Study 33341518 — intervention group
Group type: EXPERIMENTAL
Intervention: SEP-applied tape
Number of subjects: 53
Study 33341518 — intervention group
Group type: COMPARATOR
Intervention: Control (no tape)
Number of subjects: 53
Study 32920802 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated cooling vest
Number of subjects: 20
Study 32920802 — intervention group
Group type: COMPARATOR
Intervention: Deactivated cooling system (control)
Number of subjects: 20
Study 32678781 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive fit present
Number of subjects: 0
Study 32678781 — intervention group
Group type: COMPARATOR
Intervention: Cognitive fit not present
Number of subjects: 0
Study 32678781 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective measure (NASA task load index)
Number of subjects: 0
Study 32678781 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance measures (response time and accuracy)
Number of subjects: 0
Study 36014827 — intervention group
Group type: EXPERIMENTAL
Intervention: liposomal MVM
Number of subjects: 25
Study 36014827 — intervention group
Group type: COMPARATOR
Intervention: standard MVM
Number of subjects: 25
Study 33392636 — intervention group
Group type: EXPERIMENTAL
Intervention: Early apixaban therapy
Number of subjects: 100
Study 33276145 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-control treatment group (7-week smartphone-based self-control intervention)
Number of subjects: 0
Study 33276145 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention, only tracking physical activity)
Number of subjects: 0
Study 34791768 — intervention group
Group type: EXPERIMENTAL
Intervention: FAM-SOTC intervention (n=29)
Number of subjects: 72
Study 34791768 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=32)
Number of subjects: 72
Study 33393708 — intervention group
Group type: EXPERIMENTAL
Intervention: Written sun safety policy
Number of subjects: 1113
Study 33393708 — intervention group
Group type: EXPERIMENTAL
Intervention: Unwritten standard procedures on sun protection
Number of subjects: 1113
Study 33483173 — intervention group
Group type: EXPERIMENTAL
Intervention: LTH + G advertisements
Number of subjects: 1156
Study 33483173 — intervention group
Group type: EXPERIMENTAL
Intervention: LTH advertisements
Number of subjects: 1156
Study 33483173 — intervention group
Group type: COMPARATOR
Intervention: NON-ALC advertisements
Number of subjects: 1156
Study 32453288 — intervention group
Group type: EXPERIMENTAL
Intervention: cherry extract 3,600 mg/d
Number of subjects: 84
Study 32453288 — intervention group
Group type: EXPERIMENTAL
Intervention: dietitian-assisted diet modification
Number of subjects: 84
Study 36200434 — intervention group
Group type: EXPERIMENTAL
Intervention: B6 program
Number of subjects: 71
Study 36200434 — intervention group
Group type: COMPARATOR
Intervention: Control comparison program
Number of subjects: 71
Study 33783013 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuffield Early Language Intervention (NELI) programme
Number of subjects: 5879
Study 33783013 — intervention group
Group type: COMPARATOR
Intervention: Business-as-usual control group
Number of subjects: 5879
Study 32712899 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractionation-guided ablation
Number of subjects: 12
Study 32712899 — intervention group
Group type: EXPERIMENTAL
Intervention: Cavotricuspid isthmus ablation
Number of subjects: 12
Study 32712899 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardioversion
Number of subjects: 12
Study 32712899 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall arrhythmia-free survival
Number of subjects: 12
Study 32712899 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedural failure
Number of subjects: 12
Study 36018733 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin adhesive with underlying adhesive strips
Number of subjects: 120
Study 36018733 — intervention group
Group type: COMPARATOR
Intervention: Skin adhesive alone
Number of subjects: 120
Study 33561143 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP initiators
Number of subjects: 5447
Study 33561143 — intervention group
Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 5447
Study 33561143 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP initiators (women)
Number of subjects: 5447
Study 33561143 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP initiators (men)
Number of subjects: 5447
Study 35943226 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser
Number of subjects: 25
Study 35943226 — intervention group
Group type: EXPERIMENTAL
Intervention: PDL
Number of subjects: 25
Study 35943226 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 + PDL
Number of subjects: 25
Study 34398868 — intervention group
Group type: EXPERIMENTAL
Intervention: DePuy Synthes Rapidsorb Fixation System
Number of subjects: 325
Study 35457616 — intervention group
Group type: EXPERIMENTAL
Intervention: Biography and Life Storybook (BLSB) intervention, comprising eight nurse-facilitated structured sessions over three months and usual daily activities.
Number of subjects: 74
Study 35457616 — intervention group
Group type: COMPARATOR
Intervention: Routine activities (Control group).
Number of subjects: 74
Study 33594692 — intervention group
Group type: EXPERIMENTAL
Intervention: CHECK program services
Number of subjects: 1322
Study 33594692 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1322
Study 36468835 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-pulsed Nd: YAG laser 1064 nm
Number of subjects: 30
Study 36468835 — intervention group
Group type: COMPARATOR
Intervention: Intralesional botulinum toxin type-A (BTX-A)
Number of subjects: 30
Study 34420987 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuroplasticity-based computerized cognitive remediation program (Brain Fitness Program), 40 one-hour sessions
Number of subjects: 48
Study 32406100 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fluoroscopy group (LFG)
Number of subjects: 50
Study 32406100 — intervention group
Group type: COMPARATOR
Intervention: Conventional fluoroscopy group (CFG)
Number of subjects: 50
Study 35028764 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level light therapy with light-emitting diodes (LED) applied on two acupoints (CV4 and CV6)
Number of subjects: 156
Study 35028764 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment with oral Marvelon, 30 µg of ethinyl estradiol and 150 µg of desogestrel (DSG/EE)
Number of subjects: 156